Skip to content

The AMD Experts

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to turn their practice into an AMD Center of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: October 2020 | Women in Optometry

Big Change is a Small Choice

Just by adding dark adaptation testing to your practice, doctors can do more for patients at risk of developing AMD. By Julie Rodman, OD, MSc, FAAO.

Press Releases: September 28, 2020

New Annual Report Demonstrates How Dark Adaptation Makes AMD Management Easy, Accurate, and Profitable

MacuLogix announces the recent publication of “Practical Opportunities in AMD Management,” the fourth in a series of annual reports aimed at reducing avoidable vision loss.

Our Blog: September 24, 2020

Meet My Best Friend, Theia

Theia helps eye care professionals like Mary Miller, CPOT, take care of her patients – which is her favorite part as a technician at Kirman Eye.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.